603 related articles for article (PubMed ID: 19637282)
1. Toll-like receptor 4 is involved in the development of fructose-induced hepatic steatosis in mice.
Spruss A; Kanuri G; Wagnerberger S; Haub S; Bischoff SC; Bergheim I
Hepatology; 2009 Oct; 50(4):1094-104. PubMed ID: 19637282
[TBL] [Abstract][Full Text] [Related]
2. Toll-like receptors 1-9 are elevated in livers with fructose-induced hepatic steatosis.
Wagnerberger S; Spruss A; Kanuri G; Volynets V; Stahl C; Bischoff SC; Bergheim I
Br J Nutr; 2012 Jun; 107(12):1727-38. PubMed ID: 22018861
[TBL] [Abstract][Full Text] [Related]
3. Role of tumor necrosis factor α (TNFα) in the onset of fructose-induced nonalcoholic fatty liver disease in mice.
Kanuri G; Spruss A; Wagnerberger S; Bischoff SC; Bergheim I
J Nutr Biochem; 2011 Jun; 22(6):527-34. PubMed ID: 20801629
[TBL] [Abstract][Full Text] [Related]
4. Role of the inducible nitric oxide synthase in the onset of fructose-induced steatosis in mice.
Spruss A; Kanuri G; Uebel K; Bischoff SC; Bergheim I
Antioxid Redox Signal; 2011 Jun; 14(11):2121-35. PubMed ID: 21083420
[TBL] [Abstract][Full Text] [Related]
5. Toll-like receptor-4 signalling in the progression of non-alcoholic fatty liver disease induced by high-fat and high-fructose diet in mice.
Liu J; Zhuang ZJ; Bian DX; Ma XJ; Xun YH; Yang WJ; Luo Y; Liu YL; Jia L; Wang Y; Zhu ML; Ye DW; Zhou G; Lou GQ; Shi JP
Clin Exp Pharmacol Physiol; 2014 Jul; 41(7):482-8. PubMed ID: 24739055
[TBL] [Abstract][Full Text] [Related]
6. Short-Term Intake of a Fructose-, Fat- and Cholesterol-Rich Diet Causes Hepatic Steatosis in Mice: Effect of Antibiotic Treatment.
Brandt A; Jin CJ; Nolte K; Sellmann C; Engstler AJ; Bergheim I
Nutrients; 2017 Sep; 9(9):. PubMed ID: 28906444
[TBL] [Abstract][Full Text] [Related]
7. Serotonin reuptake transporter (SERT) plays a critical role in the onset of fructose-induced hepatic steatosis in mice.
Haub S; Kanuri G; Volynets V; Brune T; Bischoff SC; Bergheim I
Am J Physiol Gastrointest Liver Physiol; 2010 Mar; 298(3):G335-44. PubMed ID: 19713474
[TBL] [Abstract][Full Text] [Related]
8. Metformin protects against the development of fructose-induced steatosis in mice: role of the intestinal barrier function.
Spruss A; Kanuri G; Stahl C; Bischoff SC; Bergheim I
Lab Invest; 2012 Jul; 92(7):1020-32. PubMed ID: 22525431
[TBL] [Abstract][Full Text] [Related]
9. Toll-like receptor 4 is involved in the mechanism of early alcohol-induced liver injury in mice.
Uesugi T; Froh M; Arteel GE; Bradford BU; Thurman RG
Hepatology; 2001 Jul; 34(1):101-8. PubMed ID: 11431739
[TBL] [Abstract][Full Text] [Related]
10. Diets rich in fructose, fat or fructose and fat alter intestinal barrier function and lead to the development of nonalcoholic fatty liver disease over time.
Sellmann C; Priebs J; Landmann M; Degen C; Engstler AJ; Jin CJ; Gärttner S; Spruss A; Huber O; Bergheim I
J Nutr Biochem; 2015 Nov; 26(11):1183-92. PubMed ID: 26168700
[TBL] [Abstract][Full Text] [Related]
11. [Activation of Kupffer cell and related signal pathway proteins in the liver of high fat and high fructose diet induced NAFLD mice].
Zhu ML; Liu J; Liu YL; Yang WJ; Luo Y; Zhuang ZJ; Jiao QB; Chen JY; Yan J; Bian DX; Ma XJ; Xun YH; Shi JP
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2013 Oct; 27(5):325-7. PubMed ID: 24645313
[TBL] [Abstract][Full Text] [Related]
12. Puerarin ameliorates experimental alcoholic liver injury by inhibition of endotoxin gut leakage, Kupffer cell activation, and endotoxin receptors expression.
Peng JH; Cui T; Huang F; Chen L; Zhao Y; Xu L; Xu LL; Feng Q; Hu YY
J Pharmacol Exp Ther; 2013 Mar; 344(3):646-54. PubMed ID: 23277536
[TBL] [Abstract][Full Text] [Related]
13. Protective effect of bile acids on the onset of fructose-induced hepatic steatosis in mice.
Volynets V; Spruss A; Kanuri G; Wagnerberger S; Bischoff SC; Bergheim I
J Lipid Res; 2010 Dec; 51(12):3414-24. PubMed ID: 20847296
[TBL] [Abstract][Full Text] [Related]
14. Nuclear factor high-mobility group box1 mediating the activation of Toll-like receptor 4 signaling in hepatocytes in the early stage of nonalcoholic fatty liver disease in mice.
Li L; Chen L; Hu L; Liu Y; Sun HY; Tang J; Hou YJ; Chang YX; Tu QQ; Feng GS; Shen F; Wu MC; Wang HY
Hepatology; 2011 Nov; 54(5):1620-30. PubMed ID: 21809356
[TBL] [Abstract][Full Text] [Related]
15. The critical role of toll-like receptor (TLR) 4 in alcoholic liver disease is independent of the common TLR adapter MyD88.
Hritz I; Mandrekar P; Velayudham A; Catalano D; Dolganiuc A; Kodys K; Kurt-Jones E; Szabo G
Hepatology; 2008 Oct; 48(4):1224-31. PubMed ID: 18792393
[TBL] [Abstract][Full Text] [Related]
16. Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis.
Yamaguchi K; Yang L; McCall S; Huang J; Yu XX; Pandey SK; Bhanot S; Monia BP; Li YX; Diehl AM
Hepatology; 2007 Jun; 45(6):1366-74. PubMed ID: 17476695
[TBL] [Abstract][Full Text] [Related]
17. Female mice are more susceptible to nonalcoholic fatty liver disease: sex-specific regulation of the hepatic AMP-activated protein kinase-plasminogen activator inhibitor 1 cascade, but not the hepatic endotoxin response.
Spruss A; Henkel J; Kanuri G; Blank D; Püschel GP; Bischoff SC; Bergheim I
Mol Med; 2012 Dec; 18(1):1346-55. PubMed ID: 22952059
[TBL] [Abstract][Full Text] [Related]
18. Increased expression of toll-like receptor 4 enhances endotoxin-induced hepatic failure in partially hepatectomized mice.
Takayashiki T; Yoshidome H; Kimura F; Ohtsuka M; Shimizu Y; Kato A; Ito H; Shimizu H; Ambiru S; Togawa A; Miyazaki M
J Hepatol; 2004 Oct; 41(4):621-8. PubMed ID: 15464243
[TBL] [Abstract][Full Text] [Related]
19. Fructose-induced steatosis in mice: role of plasminogen activator inhibitor-1, microsomal triglyceride transfer protein and NKT cells.
Kanuri G; Spruss A; Wagnerberger S; Bischoff SC; Bergheim I
Lab Invest; 2011 Jun; 91(6):885-95. PubMed ID: 21423135
[TBL] [Abstract][Full Text] [Related]
20. Nonalcoholic fatty liver disease in humans is associated with increased plasma endotoxin and plasminogen activator inhibitor 1 concentrations and with fructose intake.
Thuy S; Ladurner R; Volynets V; Wagner S; Strahl S; Königsrainer A; Maier KP; Bischoff SC; Bergheim I
J Nutr; 2008 Aug; 138(8):1452-5. PubMed ID: 18641190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
